1. Home
  2. HLIO vs MNKD Comparison

HLIO vs MNKD Comparison

Compare HLIO & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helios Technologies Inc.

HLIO

Helios Technologies Inc.

HOLD

Current Price

$64.16

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$2.29

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIO
MNKD
Founded
1970
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
HLIO
MNKD
Price
$64.16
$2.29
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$65.50
$8.64
AVG Volume (30 Days)
344.3K
6.6M
Earning Date
03-02-2026
05-07-2026
Dividend Yield
0.73%
N/A
EPS Growth
23.93
N/A
EPS
1.45
0.02
Revenue
$200,727,000.00
$348,966,000.00
Revenue This Year
$3.83
$35.81
Revenue Next Year
$4.84
$11.89
P/E Ratio
$45.32
$114.75
Revenue Growth
N/A
22.23
52 Week Low
$24.76
$2.24
52 Week High
$76.47
$6.51

Technical Indicators

Market Signals
Indicator
HLIO
MNKD
Relative Strength Index (RSI) 42.32 19.33
Support Level $62.73 N/A
Resistance Level $68.56 $6.18
Average True Range (ATR) 2.54 0.13
MACD -0.04 0.06
Stochastic Oscillator 27.63 10.85

Price Performance

Historical Comparison
HLIO
MNKD

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: